Breast Cancer Clinical Trial
Official title:
Improving Surgical Decision-making in Young Women With Breast Cancer
The overall goal of this study is to qualitatively assess the surgical decision-making
process from both the patient and physician perspective
1. Conduct short in-person interviews with young women prior to surgery
2. Conduct focus groups with breast cancer survivors about their surgical decision and
experience
3. Interview surgical oncologists, plastic surgeons, medical and radiation oncologists
about their experiences and how they communicate with breast cancer patients about local
therapy decisions
4. To survey women about surgical decision-making prior to and after their consult in
conjunction with pilot testing of a web-based decision aid to support high quality
surgical decision-making in newly diagnosed young women with breast cancer.
Breast cancer in young women: Breast cancer is the most common cancer diagnosed in women
younger than age 40 in the United States, with approximately 14,000 new cases each year.
Young women face unique psychosocial challenges, most notably fertility, sexuality, and image
concerns and are at a life stage where education, career, and family are important
priorities. Concern about these issues may contribute to the greater psychosocial distress
seen in younger women at both diagnosis and in follow-up compared with older women.
Importantly, these concerns may also influence treatment decisions including receipt of
chemotherapy, adherence to endocrine therapy, and surgical decisions. Thus, attending to the
unique issues of young women may enhance not only quality of care and quality of life (QOL)
but also potentially disease outcomes.
Surgical management of breast cancer: Standard loco-regional management of breast cancer
entails partial mastectomy (i.e., breast conserving surgery) followed by radiation or
mastectomy with or without radiation. The decision depends on a number of factors including
extent of disease, family history, BRCA mutation status, and personal preference. In recent
years, an increasing number of women have elected to undergo contralateral prophylactic
mastectomy (CPM) in conjunction with surgery of the affected breast (usually choosing
bilateral mastectomy), despite a lack of clear evidence for survival benefit from this
procedure in the vast majority of women. In weighing the benefits and risks of CPM, one must
consider the absolute risk reduction of a new primary breast cancer (usually relatively
modest in the average risk survivor), the long and short-term risks of this additional
surgery including potential complications (bilateral mastectomy is associated with a greater
risk of surgical complications) and the impact on QOL. At the same time, one must consider
the competing risk of systemic recurrence of a woman's initial breast cancer. Young women, in
particular, have the greatest risk of systemic recurrence and death from their original
cancer, lowering the likelihood of benefit of CPM in preventing a new primary breast cancer.
However, while CPM rates have increased among all breast cancer patients, increased rates of
CPM are particularly pronounced among the youngest women with breast cancer, with several
studies identifying young age at diagnosis as one of the strongest determinants of
CPM.Physicians and researchers have been observing and discussing this trend for a number of
years and yet little has been done to intervene.
The goal of the proposed research is to better understand and improve the surgical decision
process in young women with breast cancer. Using qualitative research methods, we will
comprehensively assess patient experiences - both patients who have had CPM and patients who
did not - as well as physician perspectives regarding this decision. Based on these findings,
the investigators will determine how to best improve the quality of the process, e.g., by
correcting misperceptions, setting realistic expectations regarding the impact of surgery
(including reconstruction) on QOL, improving communication with health care providers, and
better management of anxiety surrounding diagnosis. This qualitative research is designed to
build on prior quantitative analyses, by gaining an in depth perspective through focus groups
and interviews, about certain issues identified as impacting the surgical decision process,
including anxiety, fear of recurrence, and patient-physician communication.
Collectively, results from the qualitative assessment will inform a future phase of this
research involving the design and subsequent development of a decision aid to help women make
informed decisions about their breast cancer surgery.
The goal of this second phase of the research is to survey women about surgical
decision-making prior to and after their consult in conjunction with pilot testing of a
web-based decision aid to support high quality surgical decision-making in newly diagnosed
young women with breast cancer.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04681911 -
Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
|
Phase 2 | |
| Completed |
NCT04890327 -
Web-based Family History Tool
|
N/A | |
| Terminated |
NCT04066790 -
Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
|
Phase 2 | |
| Completed |
NCT03591848 -
Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility
|
N/A | |
| Recruiting |
NCT03954197 -
Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients
|
N/A | |
| Terminated |
NCT02202746 -
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer
|
Phase 2 | |
| Active, not recruiting |
NCT01472094 -
The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
|
||
| Withdrawn |
NCT06057636 -
Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study
|
N/A | |
| Completed |
NCT06049446 -
Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
|
||
| Recruiting |
NCT05560334 -
A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations
|
Phase 2 | |
| Active, not recruiting |
NCT05501769 -
ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer
|
Phase 1 | |
| Recruiting |
NCT04631835 -
Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer
|
Phase 1 | |
| Completed |
NCT04307407 -
Exercise in Breast Cancer Survivors
|
N/A | |
| Recruiting |
NCT03544762 -
Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation
|
Phase 3 | |
| Terminated |
NCT02482389 -
Study of Preoperative Boost Radiotherapy
|
N/A | |
| Enrolling by invitation |
NCT00068003 -
Harvesting Cells for Experimental Cancer Treatments
|
||
| Completed |
NCT00226967 -
Stress, Diurnal Cortisol, and Breast Cancer Survival
|
||
| Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 | |
| Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
| Recruiting |
NCT06019325 -
Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy
|
N/A |